Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05824494Phase 2Unknown
Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors
Cancer of CervixCancer of the Uterine CervixCervical Cancer+3 more
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Anhui Provincial Cancer Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

hui Wang, PHD

Women's Hospital School Of Medicine Zhejiang University

Related
4 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical Neoplasms

Worked with same sponsors:

AkesoWomen's Hospital School Of Medicine Zhejiang University
Collaborated on 1 trial
Similarity Score24%

Ge Lou, PHD

The Second Affiliated Hospital of Harbin Medical University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical Neoplasms

Worked with same sponsors:

AkesoWomen's Hospital School Of Medicine Zhejiang University
Collaborated on 1 trial
Similarity Score24%

Juntao Ran

LanZhou University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Xiaojie Ma

Affiliated Hospital of North Sichuan Medical College

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Uterine Cervical Neoplasms
Similarity Score15%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Xiaoying Xue

The Second Hospital of Hebei Medical University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Kun Gao

Guangxi Medical University Cancer Center

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05824494Phase 2PrincipalInvestigator

Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

Cancer of CervixCancer of the Uterine CervixCervical Cancer+3 more
Unknown

All 1 trials loaded